(MONEY Magazine) – Buying individual foreign stocks may appear at first glance to be beyond the scope of most beginning investors (see the story on page 75). But aspiring internationalists should not be daunted. The larger markets of Europe and Asia abound with high-quality issues that are as accessible as their blue-chip American cousins. And even with the uncertainties posed by currency fluctuations, shares of leading foreign companies are less risky than a typical small American growth stock. Some major foreign stocks are listed on U.S. exchanges, and many others trade over the counter in the U.S. as American Depositary Receipts (ADRs), making them easy to buy and sell. Most important, American brokerages and newsletters provide accurate information on the prospects for such shares. To help you get started, Money surveyed 30 mutual fund managers, newsletter writers and brokerage analysts. Here are their 10 favorite foreign stocks:

Bayer. Its aspirin is familiar to headache sufferers worldwide, but the German health-care giant is also one of Europe's leading specialty-chemical producers. Drug sales are expected to grow significantly over the next three years, boosted by the U.S. introduction of cardiovascular drugs such as Adalat, which thwarts heart attacks by dissolving calcium deposits. Since the company's chemical business serves mainly European markets, it will largely be shielded from any adverse effects of fluctuations in the value of the dollar, according to Hector Sants, chief of international securities for UBS (Union Bank of Switzerland) Securities in New York City. Bayer trades as an ADR at $174, and Sants expects that the company will earn about $24 a share in 1987, up from $23.30 last year. He considers the stock cheap at only seven times 1987 earnings and recommends it for conservative investors.

Broken Hill Proprietary. This is Australia's largest company, with extensive holdings in iron ore, gold, coal, oil and gas. The recent spurt in oil and gold prices will help earnings this year and will raise the value of some of the company's properties. ''Recently, Broken Hill spun off its gold mines as a separate publicly traded business, which will highlight these values,'' says Donald Walker, a director of Touche Remnant International, an investment management firm in London. In fact, the company's undervalued assets have already attracted potential acquirers, such as Robert Holmes a Court and John Elliott, the Down Under versions of T. Boone Pickens and Carl Icahn. Since Holmes a Court now owns 29% of Broken Hill and Elliott has 18%, many analysts consider the company a likely takeover target. Broken Hill, trading as an ADR for $16, yields 3.5% and is appropriate for investors who are willing to take moderate risks.

Cadbury Schweppes. The leading British marketer of soft drinks and candy could give some ''Schweppervessence'' to your portfolio, says Paul Koerner, editor of Worldwide Investment Notes (7730 Carondelet Ave., St. Louis, Mo. 63105; semimonthly; $95 a year). ''Cadbury's growth will be propelled by its acquisition of Canada Dry last year, a joint-venture agreement it just signed with Coca-Cola to sell Coke in the U.K., and an aggressive marketing campaign for Cadbury chocolates and Schweppes tonic water around the world,'' he says. Koerner thinks profits will rise 35% this year to $3.10. Cadbury trades as an ADR for $38, 12 times estimated 1987 earnings. The stock's risk is slightly below average -- comparable to that of Coca-Cola or PepsiCo in the U.S.

Campbell Red Lake Mines. The premier gold-mining operation in Canada is prospering because of higher gold production and lower mining costs. Paul Koerner expects Campbell's earnings to rise 18% this year, provided that the price of gold -- now $420 an ounce -- remains above $400. ''Campbell's stock will also continue to be helped by investors who want to own gold companies without the stigma of investing in South African mines,'' he says. Campbell, trading on the New York Stock Exchange for $30, is above-average in risk, because its shares heavily reflect fluctuations in the volatile price of gold.

Electrolux. This Swedish-based company, not to be confused with the American business that makes Electrolux vacuum cleaners in the U.S., has been sweeping up its competitors in the household-appliance industry. Last year, Electrolux bought White Consolidated Industries, America's third largest maker of washing machines and refrigerators, and Zanussi, an Italian appliance producer. Both companies have been less profitable than their new parent. ''As Electrolux improves the performance of these subsidiaries, the company's income and market share will grow, enabling earnings to rise 16.5% this year and 17.5% in 1988,'' says Martin Wade, president of the T. Rowe Price International Fund. The stock trades as an ADR for $49, or about nine times estimated 1987 earnings of $5.55, and is moderately risky.

Hongkong Land. The company is the largest commercial landlord in Hong Kong, and its fortunes are rising with the outlook for local real estate. Since the Chinese have agreed not to interfere in the local capitalist economy for 50 years after the British withdraw from the colony in 1997, investors are regaining confidence, and real estate prices are booming. Commercial lease rates now average $42 a square foot -- double what they were three years ago. Hongkong Land is selling for about 10% less than the value of its vast holdings, says Martin Wade. Hongkong Land ADRs now trade for $2 and are appropriate for investors willing to live with the risk that China's benevolent attitude might suddenly change.

Lafarge-Coppee. This large cement producer's basic business is steady, and Hector Sants of UBS Securities is looking for a 9% rise in profits in 1987. Profit growth could accelerate during the next several years, though, as contracts are handed out for a planned $1.5 billion Disneyland-Europe theme park outside Paris. Lafarge could also profit from the proposed $7.7 billion Eurotunnel, which would connect France to Britain. The Eurotunnel still faces major political uncertainties. But if the project does go ahead, Lafarge will probably win some blockbuster contracts. Lafarge, now selling on the Paris bourse for $280, trades at 14 times estimated 1987 earnings of $20 per share and is moderately risky.

Nagoya Railroad. While many analysts think Japanese stocks are too high, George Noble, the manager of the Fidelity Overseas Fund, believes Nagoya Railroad offers hidden value. The Japanese government recently deregulated train fares, which will allow Nagoya to increase prices. In addition to railroads, Nagoya owns department stores, a trucking line and prime real estate. At $6.25, the stock, which is moderately risky, trades on the Tokyo Stock Exchange at only a fifth of its $33-a-share asset value.

Royal Dutch Petroleum. The Amsterdam-based international has been using its massive cash flow to raise dividends and buy oil reserves. In 1985 the company bought the 30.5% of Shell Oil it didn't already own, gaining the full benefit of Shell's topflight oil exploration team. Recently, Royal Dutch has been buying distressed properties in Colombia and the United States. Martin Wade of T. Rowe Price thinks that Royal Dutch stock will be among the industry's best performers when oil prices begin rising again. ''It looks like the U.S. is slipping back into its old habits and becoming more dependent on foreign oil, which will strengthen OPEC's ability to raise prices,'' he says. Royal Dutch shares, suitable for conservative investors, are traded on the New York Stock Exchange for $122 and offer a current yield of 4.3%.

Unilever NV. This is the Procter & Gamble of Europe, with an impressive stable of consumer products ranging from detergents and ice cream to tea and | baked goods. The Rotterdam-based giant reported a 31% profit gain in 1986, and Paul Koerner is projecting a 20% rise in earnings for the current year. George Noble of Fidelity's Overseas Fund thinks that Unilever's recent purchase of Chesebrough-Pond's, the American marketer of Q-Tips, Vaseline and Ragu spaghetti sauce, shows an aggressiveness that will continue to pay off for shareholders. The company is also developing innovative new products. The Clearblue pregnancy test made its debut in the U.S. last January, and the Clearplan ovulation test kit is expected to be on the market by late summer. Unilever is trading for $288 on the NYSE (the stock will probably be split five for one in June), or 16 times estimated 1987 earnings of $17.75 a share, and is suitable for conservative investors.